Just another WordPress site

Prostate Cancer

The prostate is a walnut-sized gland located below the bladder and surrounding the urethra. Its main function is to produce part of seminal fluid.

Prostate cancer is the third most common cause of cancer-related death in men, and the first amongst those over 75 years of age. It appears after the age of 40 and, generally, has a very slow growth rate.

It is most common amongst black people, people with a high consumption rate of fat in their diets, and its likelihood of appearing is greater when there are family antecedents of postate cancer.

It usually causes no symptons, and in most cases, is diagnosed by an increase of a prostate-specific antigen (PSA) detected in a blood test. Certainly of the diagnosis may only be obtained through a biopsy of the prostate, wich is an examination performed under local anesthesia and which usually does not present any great complications.

Currently, and thanks to its test-based diagnosis, most prostate cancers are detected during early stages of the disease. As a result, it may oftentimes be cured. However, even in advanced stages of the cancer, reponse to medical treatment is good and high levels of survival are reached with a good quality of life.

Treatments used at present include, during initial phases, surgery (radical prostatectomy) and radiotherapy (external or brachytherapy). In advanced stages, treatment is based on hormone therapy through wich the secretion of testicular hormones is blocked, based on the fact that prostate cancer is a hormone-dependent tomour wich requires masculine hormones (androgens) to grow.

As has already been mentioned, many prostate cancers progress very slowly, to the point that it is possible to not subject elderly people of a certain age, with a life expectancy of under 10 years, to any treatment. Instead, the tumour's growth is monitored, since along its natural development that person will probably mot show any tumour-related symptons and will pass away due to a different cause altoether.

Dr. D. Luís Pérez Llorca – Urologist

 

ASSSA Medical Services

 

 

 

The information published in this media neither substitutes nor complements in any way the direct supervision of a doctor, his diagnosis or the treatment that he may prescribe. It should also not be used for self-diagnosis.

The exclusive responsibility for the use of this service lies with the reader.

ASSSA advises you to always consult your doctor about any issue concerning your health.

Return

Testicular cancer

August 24, 2016 ASSSA Man

Testicular cancer is a disease in which malignant (cancerous) cells are formed in the tissue of one …

Cardiovascular Disease and Erectile Dysfunction

August 14, 2015 ASSSA Man

Sexual activity is accompanied by vascular changes involving the autonomic (or involuntary) nervous …

Sexual dysfunction in older men

November 10, 2016 ASSSA Man

Older men’s sexual health has been a taboo subject for years. Their sex lives did not seem to …

ASSSA Magazine 33Jan - Jun 2024

ASSSA Magazine 32Jul - Dec 2023

ASSSA Magazine 31Jan - Jun 2023

ASSSA Magazine 30Jul - Dec 2022

View all magazines

Cookies policy Privacy policy Legal notice Desarrollado por Espira

    WE CALL YOU

    Please, fill in the form and we call you

    Call us 965 200 106

    965 200 106

    Seleccione el idioma

    Escoja el idioma en el que quiere leer el blog

    Close

    NOTA INFORMATIVA

    REGLAMENTO PARA LA DEFENSA DEL ASEGURADO DE ASSSA

    Este reglamento tiene por objeto regular el funcionamiento del Servicio de Atención al Cliente y del Defensor del Asegurado de ASSSA, así como las relaciones entre ambos. Se rige por la Ley 44/2002 de 22 de noviembre, de Medidas de Reforma del Sistema Financiero y por la Orden ECO 734/2004, de 11 de marzo, sobre los departamentos y servicios de atención al cliente de las entidades financieras.

    El Reglamento para la defensa del asegurado puede solicitarlo en la siguiente dirección de correo: sacquejasyreclamaciones@asssa.es.

    Close

    INFORMATION ON THE DENTAL MEDICAL DIRECTORY

    EXCLUSIVELY FOR POLICYHOLDERS WITH A DENTAL INSURANCE POLICY

    CONTINUE